DUBLIN, Nov. 25, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/ds3sjd/global_precision) has announced the addition of the "Global Precision Medicine Market - Estimates and Forecasts Through (2015-2022)" report to their offering.
Governmental regulations and standards are sustaining the growth and development of the precision medicine market. The main aim of these regulations is to make precision medicines more adaptable and focused towards genetic diseases related to Oncology, skin, respiratory, CNS, CVD, and infectious diseases among others.
The global precision market is set to be valued at close to $88 billion by 2022 at an estimated CAGR of 12.60% from 2015 to 2022 with North America and Europe setting pace for the Rest of the World, according to Global Precision Medicine Market - Estimation & Forecast (2015-2022) report.
This report includes an overview and analysis of the precision medicine market by ecosystem, sub-markets, therapeutics and geographical regions, allowing the research to develop a comprehensive outlook of the market. The precision medicine market report presents detailed analysis of the entire precision medicine ecosystem and provides extensive insights of the different developments, trends and key participants.
The report also focuses on different sub-markets which help in the development of precision medicine solutions. The sub-market verticals are categorized into five major categories, viz. companion diagnostics, bio-markers, targeted therapeutics, Pharmacogenomics and molecular diagnostics among others in the report.
Further, the scope of the report includes the therapeutics of different disease types managed by this technology. All of the above mentioned report coverage parameters are discussed across different regions like The Americas, Europe, Asia Pacific (APAC) and Rest of the World (ROW).
- Abbott Laboratories
- Almac Group Ltd.
- Caris Life Sciences
- AB-Biotics Sa
- Asuragen, Inc.
- Biobase Gmbh (Subsidiary)
- Biomérieux Sa
- Cepheid Inc.
- Cetics Healthcare Technologies Gmbh
- GE Healthcare
- Glaxosmithkline Plc (Gsk)
- Healthcore, Inc.
- Intel Corporation
- Intomics A/S
- Johnson & Johnson
- Laboratory Corporation Of America Holdings
- Quest Diagnostics Inc
- Randox Laboratories Ltd.
- Roche Holding Ag-Br
- Takeda Pharmaceutical Company Limited
- Teva Pharmaceutical Industries Ltd.
For more information visit http://www.researchandmarkets.com/research/ds3sjd/global_precision
Laura Wood, +353-1-481-1716, [email protected]
SOURCE Research and Markets